Healthy Skepticism Library
Items published in 2012
There are 85 items in the Healthy Skepticism Library that were published in 2012.
Page 1 of 1 pages
HSL20446
Roehr B
Eli Lilly settles corrupt foreign practices complaint for $29.4m
BMJ 2012 Dec 27; 345:e8694
http://www.bmj.com/content/345/bmj.e8694
HSL20443
Sinha K
Govt to crack down on pharma-doctor nexus
Times of India 2012 Dec 26
http://articles.timesofindia.indiatimes.com/2012-12-26/india/36007441_1_drug-companies-drug-promotion-dcgi
HSL20442
Rodwin MA
Independent Clinical Trials to Test Drugs: The Neglected Reform
Saint Louis University Journal of Health Law & Policy 2012 Dec 24; 6:(12-58):113
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2193594
HSL20500
Ray K
Doc’s plaint stops vaccine ad on TV
The Deccan Herald 2012 Dec 14
http://www.deccanherald.com/content/298660/docs-plaint-stops-vaccine-ad.html
HSL20444
Boumil MM
Off-Label Marketing and the First Amendment
NEJM 2012 Dec 12; 368:103-105
http://www.nejm.org/doi/full/10.1056/NEJMp1214926
HSL20445
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L
Industry sponsorship and research outcome
The Cochrane Library 2012 Dec 12; (12):
http://onlinelibrary.wiley.com/doi/10.1002/14651858.MR000033.pub2/full
HSL19717
Segatto C
O real risco das novas pílulas
Época 2012 Dec 9
http://revistaepoca.globo.com/Saude-e-bem-estar/noticia/2011/12/o-real-risco-das-novas-pilulas.html
HSL20499
Hegde BM
Money is Mammon in pharmaceutical world
The Hindu 2012 Dec 9
http://www.thehindu.com/opinion/open-page/money-is-mammon-in-pharmaceutical-world/article4179010.ece
HSL20438
AstraZeneca’s cancer drug patent rejected
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295062/astrazenecas-cancer-drug-patent-rejected.html
HSL20439
Medicines for needy
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295055/medicines-needy.html
HSL20440
Kumar C
Govt pact with generic drug seller ‘illegal’
The Deccan Herald 2012 Nov 28
http://www.deccanherald.com/content/295090/govt-pact-generic-drug-seller.html
HSL20441
Swan N
The High Costs of Pharmaceuticals in Australia
Health Report : Radio National 2012 Nov 260
http://www.abc.net.au/radionational/programs/healthreport/the-high-costs-of-pharmaceuticals-in-australia/4392196#transcript
HSL20432
Srinivasan S
Is the shift away from cost-plus drug pricing desirable? - NO
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-no/article4127203.ece?homepage=true
HSL20433
Shah DG
Is the shift away from cost-plus drug pricing desirable? - YES
The Hindu Business Line 2012 Nov 23
http://www.thehindubusinessline.com/opinion/is-the-shift-away-from-costplus-drug-pricing-desirable-yes/article4127199.ece?homepage=true
HSL20434
Ferner R
A short history of pharmaceutical marketing
BMJ 2012 Nov 20; 345:e7801
http://www.bmj.com/content/345/bmj.e7801
HSL20435
Karmali N
India's Pharma Kings Are The Country's Big Winners
Forbes 2012 Oct 25
http://www.forbes.com/sites/naazneenkarmali/2012/10/25/indias-pharma-kings-are-the-countrys-big-winners/
HSL20437
Devinney T
Integrity pays dividends: the case for minding your own business
The Conversation 2012 Oct 25
http://theconversation.edu.au/integrity-pays-dividends-the-case-for-minding-your-own-business-9301
HSL20436
Preston C, Valdez M, Bond K
Strengthening Medical Product Regulation in Low- and Middle-Income Countries
PLoS Med 2012 Oct 23; 9:(10):
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001327
HSL20422
Joelving F
Exclusive: Abbott suspends giving gifts to doctors in India
Reuters 2012 Oct 16
http://www.reuters.com/article/2012/10/16/us-abbott-india-doctors-idUSBRE89F1N820121016
HSL20421
Lewis H
Lies, damn lies and drug trials
New Statesman 2012 Oct 4
http://www.newstatesman.com/sci-tech/sci-tech/2012/10/lies-damn-lies-and-drug-trials
HSL20282
Supreme Court asks Centre not to alter pricing system for essential drugs
The Economic Times 2012 Oct 3
http://articles.economictimes.indiatimes.com/2012-10-03/news/34238803_1_essential-medicines-prices-control-steep-hike
HSL20284
Reynolds M
Australian Pharma companies bow to demanding doctors
6minutes.com 2012 Oct 2
http://www.6minutes.com.au/news/latest-news/transparency-will-expose-demanding-doctors
HSL20261
Thomas C
Medical journals: 'information-laundering for Big Pharma'?
The Ethical Nag 2012 Sep 26
http://ethicalnag.org/2012/09/26/medical-journals-information-laundering-big-pharma/
HSL20258
Luthra S
U. forgoes action against prof after study fraud
The Brown Daily Herald 2012 Sep 14
http://www.browndailyherald.com/u-forgoes-action-against-prof-after-study-fraud-1.2762909#.UFrj5I51A21
HSL20257
Bates A
How to Get More Sales from Your Sales Force Efforts
eyeforpharma 2012 Sep 4
http://social.eyeforpharma.com/column/how-get-more-sales-your-sales-force-efforts
HSL20402
Djulbegovic B, Hozo I, Beckstead J, Tsalatsanis A, Pauker SG
Dual processing model of medical decision-making
BMC Medical Informatics and Decision Making 2012 Sep 3; 12:(94):
http://www.biomedcentral.com/1472-6947/12/94/abstract
HSL20259
Lee M, Hirschler B
China's 'wild east' drug store
Reuters 2012 Aug 28
http://uk.reuters.com/article/2012/08/28/uk-china-pharmaceuticals-idUKBRE87R0OE20120828
HSL20260
Light DW, Lexchin JR
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012 Aug 11;
http://www.bmj.com/content/345/bmj.e4348
HSL20262
Harvey K
TGA failure gives Nurofen consumers a headache
The Conversation 2012 Aug 10
http://theconversation.edu.au/tga-failure-gives-nurofen-consumers-a-headache-8762
HSL20263
Bita N
Pharmaceutical companies spends $30m wining, dining doctors
The Australian 2012 Aug 10
http://www.theaustralian.com.au/news/health-science/pharmaceutical-companies-spends-30m-wining-dining-doctors/story-e6frg8y6-1226447086707
HSL20253
Unnikrishnan C
Doctors' freebies to be taxed
Times of India 2012 Aug 7
http://articles.timesofindia.indiatimes.com/2012-08-07/mumbai/33081949_1_freebies-pharma-firms-organization-of-pharmaceutical-producers
HSL20255
Kesselheim AS, Wang B, Studdert DM, Avorn J
Conflict of Interest Reporting by Authors Involved in Promotion of Off-Label Drug Use: An Analysis of Journal Disclosures
PLoS Med 2012 Aug 7; 9:(8):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001280
HSL20314
Jones MI
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2012 Aug 4; 323:1-7
http://www.bmj.com/content/323/7309/378.1
HSL20249
Barker A
EU to charge two drugmakers over generics
The Financial Times 2012 July 25
http://www.ft.com/intl/cms/s/0/d9ce8402-d671-11e1-bd9c-00144feabdc0.html#axzz21t7yPXo0
HSL20247
Fisher JA, Kalbaugh CA
United States Private-Sector Physicians and Pharmaceutical Contract Research: A Qualitative Study
PLoS Med 2012 July 24; 9:(7):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001271
HSL20251
Saying 'no thanks' to the pharmaceutical industry's undue influence
Prescrire 2012 July 23;
HSL20254
Sharma H
Pharma firms funding foreign trips for doctors
IBN Live 2012 July 18
http://ibnlive.in.com/news/pharma-firms-funding-foreign-trips-for-doctors/271997-3-236.html
HSL20246
ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
HAI Europe 2012 July 16
HSL20248
‘Sponsored’ doctors under scanner
The New Indian Express 2012 July 11
http://newindianexpress.com/nation/article563870.ece
HSL20245
Glekin J
India's pro-poor policy may be getting healthier
Reuters Breakingviews 2012 July 5
http://in.reuters.com/article/2012/07/05/breakingviews-generic-drugs-idINDEE86404Y20120705?feedType=RSS&feedName=globalCoverage2
HSL20228
Glaxo to pay $3 bn for largest health fraud in US
The Washington Post 2012 July 3
http://www.washingtonpost.com/national/health-science/glaxosmithkline-to-pay-3b-in-largest-healthcare-fraud-settlement-in-us-history/2012/07/02/gJQArBKIJW_story_1.html
HSL20226
GlaxoSmithKline to pay $3bn in US drug fraud scandal
BBC News 2012 July 2
http://www.bbc.co.uk/news/world-us-canada-18673220
HSL20227
Karlin M
Big Pharma Drug Company Gets Fined 3 Billion Dollars for Marketing Abuse of Drugs, But No Criminal Charges
The Buzzflash Blog 2012 July 2
http://blog.buzzflash.com/node/13580
HSL20204
Ray K
Drug companies fleecing consumers: Study
The Deccan Herald 2012 Jun 15
http://www.deccanherald.com/content/257136/drug-companies-fleecing-consumers-study.html
HSL20225
Kaplan WA, Ritz LS, Vitello M, Wirtz VJ
Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010
Health Policy 2012 Jun 13;
http://www.healthpolicyjrnl.com/article/S0168-8510(12)00132-7/abstract
HSL20205
Weissman R, So A
Generating Antibiotic Incentives Now: GAIN Or Just Greed
Citizen Vox 2012 Jun 12
http://www.citizenvox.org/2012/06/12/antibiotic-resistance-gain-ac/
HSL20161
Dabade G
When drug regulators play with people’s lives
The Deccan Herald 2012 May 22
http://www.deccanherald.com/content/251489/when-drug-regulators-play-peoples.html
HSL19768
Godlee F
Research misconduct is widespread and harms patients
BMJ 2012 May 1; 344:
http://www.bmj.com/content/344/bmj.e14
HSL19998
Big Pharma spends over €40 million per year lobbying in the EU, dwarfing public health NGOs
HAI Europe 2012 Mar 28
http://www.corporateeurope.org/pressreleases/2012/big-pharma-spends-over-40-million-year-lobbying-eu-dwarfing-public-health-ngos
HSL19999
Silverman E
Pharma Execs Admit: ‘Our Model Is Broken’
Pharmalot 2012 Mar 21
http://www.pharmalot.com/2012/03/pharma-execs-admit-our-model-is-broken/
HSL19977
Dunlevy S
Australian Big Pharma to derail gravy train Ken Harvey
The Australian 2012 Mar 19
http://www.theaustralian.com.au/news/health-science/big-pharma-to-derail-gravy-train/story-e6frg8y6-1226303285769
HSL19976
O'Brien M
'Unethical': NHMRC to reveal stance on homeopathy
Medical Observer 2012 Mar 14
http://www.medicalobserver.com.au/news/unethical-nhmrc-to-reveal-stance-on-homeopathy?utm_medium=email&utm_campaign=Medical+Observer+eNews+-+14032012&utm_content=Medical+Observer+eNews+-+14032012+CID_a5bbeb08c9b38c8cb25925305583a957&utm_source=Email+marketing+software&utm_term=Unethical+NHMRC+to+reveal+stance+on+homeopathy
HSL19961
Bajaj V, Pollack A
If Novartis wins, prices of drugs could sky-rocket
The Deccan Herald 2012 Mar 8
http://www.deccanherald.com/content/232801/if-novartis-wins-prices-drugs.html
HSL19941
Reid-Henry S
Novartis vs India: the showdown approaches
New Internationalist Blog 2012 Feb 28
http://www.newint.org/blog/2012/02/28/novartis-india-court-case-approaches/?utm_source=ni-enews-au-2012-03-05&utm_medium=email-html&utm_content=body&utm_campaign=new-internationalist-enews-oz-shop
HSL19996
Metherell M
Hunt for the truth behind diet pill
The Sydney Morning Herald 2012 Feb 18
http://www.smh.com.au/national/health/hunt-for-the-truth-behind-diet-pill-20120217-1tei9.html
HSL19997
Baloch F
Spurious drugs case: Pharma association’s acting chief blasts industry, regulator
The Express Tribune 2012 Feb 17
http://tribune.com.pk/story/337738/spurious-drugs-case-pharma-associations-acting-chief-blasts-industry-regulator/
HSL19849
Imprensa RP
Anvisa não pode mais vetar publicidade de medicamentos, diz Justiça
Portal Imprensa 2012 Feb 3
http://portalimprensa.uol.com.br/cdm/caderno+de+midia/47045/anvisa+nao+pode+mais+vetar+publicidade+de+medicamentos+diz+justica
HSL20000
Pickett FA
Misrepresentation of Scientific Studies Misleads Professional Caregivers
Dentition 2012 Feb; 1:(1):14-19
http://www.thedentition.com/ojs/index.php/dent/article/view/3/19
HSL19884
Brody H
Opinion: Celebrities Pushing Drugs?
The Scientist 2012 Jan 30
http://the-scientist.com/2012/01/30/opinion-celebrities-pushing-drugs/
HSL19821
Cohen D
Deborah Cohen: Roche responds
BMJ Group Blogs 2012 Jan 27
http://blogs.bmj.com/bmj/2012/01/27/deborah-cohen-roche-responds/
HSL19794
Bosch X, Esfandiari B, McHenry L
Challenging Medical Ghostwriting in US Courts
PLoS Med 2012 Jan 24; 9:(1):
http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001163
HSL19883
Key Opinion Leaders Who Lend Their Names to Ghostwritten Medical Articles Should Be Held Legally Liable, Article States
Baum, Hedlund, Aristei & Goldman 2012 Jan 24
HSL19796
Collins G
Call to axe starter packs
6minutes 2012 Jan 23
http://www.6minutes.com.au/news/latest-news/call-to-axe-starter-packs
HSL19783
Alexander J
Health ministry asks state drug controllers to closely monitor misleading ads on vitamins, creams
Pharmabiz 2012 Jan 18
http://pharmabiz.com/NewsDetails.aspx?aid=67061&sid=1
HSL19817
Laurance J
Implant danger extends to all medical devices
The Independent 2012 Jan 18
http://www.independent.co.uk/life-style/health-and-families/health-news/implant-danger-extends-to-all-medical-devices-6291116.html
HSL19816
Pear R
U.S. to Force Drug Firms to Report Money Paid to Doctors
The New York Times 2012 Jan 16
http://www.nytimes.com/2012/01/17/health/policy/us-to-tell-drug-makers-to-disclose-payments-to-doctors.html?_r=3&pagewanted=all
HSL19772
Dabade G
With 100% FDI in pharma, medicines may soon cost more
The Deccan Herald 2012 Jan 15
http://www.deccanherald.com/content/215612/with-100-fdi-pharma-medicines.html
HSL19763
Khor M
TWN Info Service on Intellectual Property Issues
Third World Network 2012 Jan 14
www.twnside.org.sg
HSL19882
Voreacos D, Cronin Fisk M, Feeley J
J&J Marketed Risperdal for Kids After FDA Warnings, Jurors Told
Bloomberg 2012 Jan 14
http://www.bloomberg.com/news/2012-01-13/j-j-marketed-risperdal-to-children-despite-u-s-fda-warnings-jurors-told.html
HSL19765
Braillon A
Drug industry is now biggest defrauder of US government
BMJ 2012 Jan 10; 344:
http://www.bmj.com/content/344/bmj.d8219
HSL19767
Christensen M, Knop FK
The unobtainable placebo: control of independent clinical research by industry?
The Lancet 2012 Jan 7; 379:(9810):30
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60024-5/fulltext
HSL19766
Shankar PR, Singh KK, Piryani RM
Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school
BMC Research Notes 2012 Jan 6; 5:(8):
http://www.biomedcentral.com/1756-0500/5/8/abstract
HSL19771
Fiddamen B
APA Use Restraints on Blogger
Seroxat Sufferers: Stand Up and Be Counted 2012 Jan 4
http://networkedblogs.com/skM9J?mid=56
HSL19769
Lehman R, Loder E
Missing clinical trial data
BMJ 2012 Jan 3; 344:
http://www.bmj.com/content/344/bmj.d8158
HSL19995
Cardenal Taján J
GSK fined after over vaccine trials; 14 babies reported dead
Buenos Aires Herald 2012 Jan 3
http://www.buenosairesherald.com/article/88922/gsk-lab-fined-over-vaccine-tests-that-killed-14--babies
HSL20203
Moynihan R
Kissing goodbye to key opinion leaders
Medical Journal of Australia 2012; 196:(11):671
https://www.mja.com.au/journal/2012/196/11/kissing-goodbye-key-opinion-leaders
HSL20250
Lexchin J, Vitry A
Should the C in CME Stand for Commercial?
Southern Med Review 2012; 5:(1):3-5
http://www.southernmedreview.org/index.php/smr/article/view/1028/31
HSL20252
Grills NJ
The ethics of industry sponsorship of charities
MJA 2012; 197:(3):139
https://www.mja.com.au/journal/2012/197/3/ethics-industry-sponsorship-charities
HSL20266
Wolfe SM
The seven-year rule for safer prescribing
Aust Prescr 2012; 35:(5):138-9
http://www.australianprescriber.com/magazine/35/5/138/9
HSL20283
Puliyel J
Compensation for Victims of Clinical Trials: A Discussion on How Current Indian Rules and Guidelines are Hurting India
Journal of Clinical and Diagnositic Research 2012;
http://www.jcdr.net/articles/pdf/2389/jcdr-6-1367.pdf
HSL19994
McNamara S
Antidepressant research divides experts
MJA Insight 2012 03 12; (9):
http://www.mjainsight.com.au/view?post=antidepressant-research-divides-experts&post_id=8416&cat=issue-9-12-march-2012
HSL20243
Phillips & Cohen
Whistleblower ('qui tam') lawsuit against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012
http://www.glaxowhistleblowers.com/lawsuit/
HSL20244
Phillips & Cohen
Glaxo’s settlement agreement and the government’s charges against Glaxo
Glaxo Whistleblower Case: Off-label marketing and kickbacks settlement 2012
http://www.glaxowhistleblowers.com/settlement-agreement/
HSL20256
Harvey K
Pfizer Includes Foreign Corrupt Practices Act Violations in Its Arsenal of Illegal Activities
Worst Pills, Best Pills 2012 Sep
https://www.worstpills.org/login.cfm?redirected=1&page=/member/newsletter.cfm&qString=n%5Fid%3D812
HSL20296
Boldrin M, Levine DK
The Case Against Patents
Federal Reserve Bank of St Louis 2012
http://research.stlouisfed.org/wp/more/2012-035
Page 1 of 1 pages
